Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 See also  





2 References  














CPK-MB test






العربية
Türkçe
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


CPK-MB test
Kinetics of cardiac markers in myocardial infarction with or without reperfusion treatment
Reference range2 to 19.5 U/L (at 37 C in adults),[1]
some places 5 to 25 IU/L[2]
LOINC49551-5, 51506-4, 2154-3, 13969-1, 32673-6, 38482-6

The CPK-MB test (creatine phosphokinase-MB), also known as CK-MB test, is a cardiac marker[3] used to assist diagnoses of an acute myocardial infarction, myocardial ischemia, or myocarditis. It measures the blood level of CK-MB (creatine kinase myocardial band), the bound combination of two variants (isoenzymes CKM and CKB) of the enzyme phosphocreatine kinase.[citation needed]

In some locations, the test has been superseded by the troponin test. However, recently, there have been improvements to the test that involve measuring the ratio of the CK-MB1 and CK-MB2 isoforms.[4]

The newer test detects different isoforms of the B subunit specific to the myocardium whereas the older test detected the presence of cardiac-related isoenzyme dimers.[citation needed]

Many cases of CK-MB levels exceeding the blood level of total CK have been reported, especially in newborns with cardiac malformations, especially ventricular septal defects. This reversal of ratios is in favor of pulmonary emboli or vasculitis. An autoimmune reaction creating a complex molecule of CK and IgG should be taken into consideration.[5]

See also

[edit]

References

[edit]
  1. ^ "CREATINE KINASE – MB CK-MB LQ" (PDF).
  • ^ Cabaniss, C. Daniel (1990), Walker, H. Kenneth; Hall, W. Dallas; Hurst, J. Willis (eds.), "Creatine Kinase", Clinical Methods: The History, Physical, and Laboratory Examinations (3rd ed.), Boston: Butterworths, ISBN 978-0-409-90077-4, PMID 21250193, retrieved 2022-04-18
  • ^ Guzy PM (December 1977). "Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction". West. J. Med. 127 (6): 455–60. PMC 1237914. PMID 339548.
  • ^ "Use of Cardiac Markers in the Emergency Department: - eMedicine". Retrieved 2009-01-10.
  • ^ Boucek RJ Jr; Kasselberg AG; Boerth RC; Parrish MD; Graham TP Jr (July 1982). "Myocardial injury in infants with congenital heart disease: evaluation by creatine kinase MB isoenzyme analysis". Am J Cardiol. 50 (1): 129–35. doi:10.1016/0002-9149(82)90018-2. PMID 7090995.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=CPK-MB_test&oldid=1166759732"

    Categories: 
    Blood tests
    Cardiology
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
    All articles with unsourced statements
    Articles with unsourced statements from April 2022
    Articles with unsourced statements from March 2021
     



    This page was last edited on 23 July 2023, at 15:39 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki